Skip to main content

Peer Review reports

From: Safety and effectiveness of tofacitinib in Korean adult patients with ulcerative colitis: post-marketing surveillance study

Original Submission
6 Feb 2024 Submitted Original manuscript
4 Apr 2024 Reviewed Reviewer Report
5 Apr 2024 Reviewed Reviewer Report
8 May 2024 Author responded Author comments - Jae Hee Cheon
Resubmission - Version 2
8 May 2024 Submitted Manuscript version 2
14 May 2024 Author responded Author comments - Jae Hee Cheon
Resubmission - Version 3
14 May 2024 Submitted Manuscript version 3
29 May 2024 Reviewed Reviewer Report
31 May 2024 Reviewed Reviewer Report
28 Jun 2024 Author responded Author comments - Jae Hee Cheon
Resubmission - Version 4
28 Jun 2024 Submitted Manuscript version 4
16 Jul 2024 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
23 Jul 2024 Editorially accepted
19 Aug 2024 Article published 10.1186/s12876-024-03336-2

You can find further information about peer review here.

Back to article page